The FDA cleared Cytrans Elashield, a synthetic bone grafting material from GC America, Inc. (Alsip, US), under 510(k) K253317 on July 6, 2026.
- Source
- U.S. FDA 510(k) database
accessdata.fda.gov - Published
- July 6, 2026
- Type
- FDA
- Checked
- October 2, 2026
